SSI Diagnostica Group

medical devices

About

SSI Diagnostica Group is a global leader in developing, manufacturing, and distributing in vitro diagnostic (IVD) products, focusing on infectious and tropical diseases. Headquartered in Hillerød, Denmark, the company operates facilities in Denmark, the United States, and China, employing over 600 people worldwide. It was originally part of the Danish National Reference Center and is now privately held by Adelis Equity. The company specializes in producing high-quality antisera for vaccine development and rapid diagnostic tests for disease surveillance and diagnosis. Its product portfolio addresses gastrointestinal, respiratory, and bloodborne diseases, including tropical diseases like dengue. SSI Diagnostica comprises four companies: SSI Diagnostica A/S, TECHLAB®, CTK Biotech, and Beijing Genesee Biotech, Inc., each contributing to its extensive range of diagnostic solutions. The company has seen significant growth since its establishment in 2016, particularly in response to the COVID-19 pandemic, where it developed high-quality rapid tests at scale.

Technologies

Cloudflare DNS Outlook WP Engine Magento AI

Keywords

microbiology diagnostics ivd medical equipment manufacturing rapid antigen tests pcr testing bacterial strains vaccine quality control animal blood products vaccine development culture media antisera production antigens diagnostic kits disease monitoring antisera vaccines parasitology diagnostics tropical disease testing sample transport media government b2b iso 13485 certified serology disease surveillance infectious disease diagnostics sexually transmitted infections diagnostics outbreak investigation tools pcr diagnostic research

Location

2 Herredsvejen, Hillerod, Capital Region of Denmark, Denmark, 3400

Related Companies

Companies in the same industry